Providing investors with the
tools to make informed decisions.
Providing investors with the
tools to make informed decisions.
 Tracking 1134 U.S. listed China Stocks and Counting...
 Tracking 2412 U.S. Stocks and Counting...

 Organovo Holdings (PINK:ONVO)

Company Description

Organovo Holdings, Inc. develops NovoGen three-dimensional (3D) human tissue printing technology for creating tissue on demand for research and surgical applications. Its NovoGen 3D printing technology is a platform that works across various tissue and cell types. Organovo Holdings, Inc. serves physicians and researchers involved in the fields of cardiovascular medicine, medical research, and transplant medicine. The company was founded in 2007 and is based in San Diego, California.

Web site: http://www.organovo.com

Last updated February 16, 2012